Probiotic Formulation and Method for Weight Loss Treatment

Abstract

A composition of probiotics is provided which promotes weight loss and maintenance thereof. More particularly, a probiotic mixture of Lactobacillus gasseri, Lactobacillus fermentum , and Lactobacillus rhamnosus are provided to reduce body adiposity, decrease inflammation of adipose tissue, and enhance metabolism in optional combination with prebiotics and excipients such as flow agents and binders. A method of administering the probiotic composition to an individual user is also provided.

What is claimed is: 
     
         1 . A probiotic formulation, comprising:
 a mixture of beneficial probiotic microflora, comprising
   Lactobacillus gasseri, Lactobacillus fermentum , and  Lactobacillus rhamnosus ; and a pharmaceutically acceptable carrier, wherein an outer housing of the carrier is formed of cellulose, the cellulose being configured to maintain the formulation in intestinal fluid. 
   
     
     
         2 . The probiotic formulation of  claim 1 , wherein the mixture of beneficial probiotic microflora comprises from about 10 to 50 weight percent  Lactobacillus gasseri , from about 10 to 50 weight percent  Lactobacillus fermentum , and from about 10 to 50 weight percent  Lactobacillus rhamnosus.    
     
     
         3 . The probiotic formulation of  claim 1 , wherein the mixture of beneficial probiotic microflora comprises from about 30 to 35 weight percent  Lactobacillus gasseri , from about 30 to 35 weight percent  Lactobacillus fermentum , and from about 30 to 35 weight percent  Lactobacillus rhamnosus.    
     
     
         4 . The probiotic formulation of  claim 1 , wherein the mixture of beneficial probiotic microflora is about between 5 billion and 50 billion colony forming units (CFU). 
     
     
         5 . The probiotic formulation of  claim 1 , wherein the mixture of beneficial probiotic microflora is 37.5 billion CFU. 
     
     
         6 . The probiotic formulation of  claim 1 , wherein the pharmaceutically acceptable carrier is a capsule. 
     
     
         7 . The probiotic formulation of  claim 1 , wherein the pharmaceutically acceptable carrier is a tablet. 
     
     
         8 . The probiotic formulation of  claim 1 , wherein the pharmaceutically acceptable carrier is a food product. 
     
     
         9 . The probiotic formulation of  claim 1 , further comprising a prebiotic acting as a food source for the mixture of probiotics. 
     
     
         10 . The probiotic formulation of  claim 9 , wherein the prebiotic includes inulin. 
     
     
         11 . The probiotic formulation of  claim 9 , wherein the prebiotic includes oligofructose. 
     
     
         12 . The probiotics formulation of  claim 9 , wherein the prebiotic includes a non-digestible oligosaccharide. 
     
     
         13 . A method of colonizing gastrointestinal microflora in overweight individuals comprising administering a therapeutically effective amount of a mixture of beneficial probiotic microflora and a pharmaceutically acceptable carrier. 
     
     
         14 . The method of  claim 1 , wherein the therapeutically effective amount is from about 10 billion to 50 billions colony forming units (CFU) of the mixture of beneficial probiotic microflora. 
     
     
         15 . The method of  claim 1 , wherein the therapeutically effective amount is 37.5 billion CFU of the mixture of beneficial probiotic microflora.